Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Sucampo Pharmaceuticals, Inc.    SCMP   US8649091068

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
04/28/2015 04/29/2015 04/30/2015 05/01/2015 05/04/2015 Date
18.69(c) 18.54(c) 17.76(c) 18.57(c) 18.88(c) Last
739 394 407 543 426 401 472 530 609 629 Volume
-4.20% -0.80% -4.21% +4.56% +1.67% Change
More quotes
Financials ($)
Sales 2015 132 M
EBIT 2015 43,3 M
Net income 2015 28,1 M
Finance 2015 59,9 M
Yield 2015 -
Sales 2016 151 M
EBIT 2016 55,7 M
Net income 2016 36,6 M
Finance 2016 104 M
Yield 2016 -
PER 2015 32,99
PER 2016 24,94
EV / Sales 2015 5,99x
EV / Sales 2016 4,94x
Capitalization 852 M
More Financials
Company
Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company which engages in research, discovery, development and commercialization of proprietary drugs in the Americas, Europe and Asia.It is developing prostones, which are ion channel activators, to treat gastrointestinal, ophthalmic and... 
More about the company
Surperformance© ratings of Sucampo Pharmaceuticals, I
Trading Rating : Investor Rating :
More Ratings
Latest news on SUCAMPO PHARMACEUTICALS, I
04/23 SUCAMPO PHARMACEUTICALS : Announces Webcast of Its Presentation at the 14th Annu..
04/22 Sucampo Announces First Quarter 2015 Earnings Call
04/22 SUCAMPO PHARMACEUTICALS : Announces First Quarter 2015 Earnings Call
04/14 SUCAMPO PHARMACEUTICALS : Regulation FD Disclosure (form 8-K)
04/07 Sucampo Announces Webcast of Its Presentation at the 14th Annual Needham Heal..
03/30 SUCAMPO PHARMACEUTICALS : Entry into a Material Definitive Agreement, Other Even..
03/26 SUCAMPO PHARMACEUTICALS : Announces Proposed Public Offering by Selling Stockhol..
03/26 Sucampo Prices Public Offering of Common Stock by Selling Stockholders
More news
Sector news : Bio Therapeutic Drugs
05/04 MEDIVATION : Announces Participation at Upcoming Investor Conference
05/04 QIAGEN NV : partners with world’s largest sequencing provider
05/04 Intercept to Report First Quarter 2015 Financial Results on May 11 and Presen..
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
04/03 INSIDERINSIGHTS.COM DAILY ROUND UP 4 : Agco, bh, rwc, vnce
03/26 Midday Gainers / Losers
03/26 Sucampo prices equity offering
03/26 PREMARKET GAINERS / LOSERS AS OF 9 : 10 am
03/26 Sucampo off 14% premarket on pending stock sales by shareholders


Comments 
Advertisement
Chart SUCAMPO PHARMACEUTICALS, I
Duration : Period :
Sucampo Pharmaceuticals, I Technical Analysis Chart | SCMP | US8649091068 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF